子宫输卵管造影在不孕女性输卵管通畅度评估中的临床实践中国专家共识(2026年版)

中国医师协会妇产科医师分会 广西医师协会生殖医学专业委员会

中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (2) : 182-195.

PDF(1158 KB)
PDF(1158 KB)
中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (2) : 182-195. DOI: 10.19538/j.fk2026020112
专家共识

子宫输卵管造影在不孕女性输卵管通畅度评估中的临床实践中国专家共识(2026年版)

作者信息 +
文章历史 +

引用本文

导出引用
中国医师协会妇产科医师分会 广西医师协会生殖医学专业委员会. 子宫输卵管造影在不孕女性输卵管通畅度评估中的临床实践中国专家共识(2026年版)[J]. 中国实用妇科与产科杂志. 2026, 42(2): 182-195 https://doi.org/10.19538/j.fk2026020112
中图分类号: R711.6   

参考文献

[1]
宗璇, 乔杰. 女性生育力及其影响因素[J]. 中国实用妇科与产科杂志, 2022, 38(6):580-585. DOI:10.19538/j.fk2022060102.
[2]
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss:a committee opinion[J]. Fertil Steril, 2020, 113(3):533-535.DOI:10.1016/j.fertnstert.2019.11.025.
[3]
Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care,2017[J]. Hum Reprod, 2017, 32(9):1786-1801. DOI:10.1093/humrep/dex234.
[4]
Boivin J, Bunting L, Collins JA, et al. International estimates of infertility prevalence and treatment-seeking:potential need and demand for infertility medical care[J]. Hum Reprod, 2007, 22(6):1506-1512. DOI:10.1093/humrep/dem046.
[5]
Agarwal A, Mulgund A, Hamada A, et al. A unique view on male infertility around the globe[J]. Reprod Biol Endocrinol, 2015, 13:37. DOI:10.1186/s12958-015-0032-1.
[6]
Zheng D, Zhou Z, Li R, et al. Consultation and treatment behaviour of infertile couples in China:a population-based study[J]. Reprod Biomed Online, 2019, 38(6):917-925. DOI:10.1016/j.rbmo.2018.11.034.
[7]
杨静薇, 邓成艳, 黄学锋, 等. 中华医学会生殖医学分会2018年度辅助生殖技术数据报告[J]. 生殖医学杂志, 2021, 30(4):419-425. DOI:10.3969/j.issn.1004-3845.2021.04.001.
[8]
李兵, 袁冬存. 重视输卵管梗阻介入治疗中的个体化[J]. 中国实用妇科与产科杂志, 2026, 42(1):55-57.DOI:10.19538/j.fk2026010114.
[9]
Dreyer K, van Rijswijk J, Mijatovic V, et al. Oil-based or water-based contrast for hysterosalpingography in infertile women[J]. N Engl J Med, 2017, 376(21):2043-2052. DOI:10.1056/NEJMoa1612337.
[10]
冯帆, 倪亚莉, 朱大林, 等. 评价子宫输卵管碘油造影后自然妊娠结局[J]. 生殖医学杂志, 2015, 24(5):368-371. DOI:10.3969/j.issn.1004-3845.2015.05.006.
[11]
冒韵东. 输卵管阻塞性病变的诊断选择[J]. 中国实用妇科与产科杂志, 2019, 35(1):68-72. DOI:10.19538/j.fk2019010116.
[12]
王银, 杜子伟, 徐文健, 等. 原发不孕症患者对不同碘油对比剂在子宫输卵管造影后结果的比较分析[J]. 实用放射学杂志, 2024, 40(9):1514-1517. DOI:10.3969/j.issn.1002-1671.2024.09.027.
[13]
Zhang J, Lan W, Wang Y, et al. Ethiodized poppyseed oil-based contrast medium is superior to water-based contrast medium during hysterosalpingography regarding image quality improvement and fertility enhancement:A multicentric,randomized and controlled trial[J]. EClinicalMedicine, 2022, 46:101363. DOI:10.1016/j.eclinm.2022.101363.
[14]
Uzun O, Findik S, Danaci M, et al. Pulmonary and cerebral oil embolism after hysterosalpingography with oil soluble contrast medium[J]. Respirology, 2004, 9(1):134-136. DOI:10.1111/j.1440-1843.2003.00524.x.
[15]
Satoh M, Aso K, Katagiri Y. Thyroid dysfunction in neonates born to mothers who have undergone hysterosalpingography involving an oil-soluble iodinated contrast medium[J]. Horm Res Paediatri, 2015, 84(6):370-375. DOI:10.1159/000439381.
[16]
Johnson NP, Farquhar CM, Hadden WE, et al. The FLUSH trial--flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography:a randomized trial[J]. Hum Reprod, 2004, 19(9):2043-2051. DOI:10.1093/humrep/deh418.
[17]
Johnson NP, Kwok R, Stewart AW, et al. Lipiodol fertility enhancement:two-year follow-up of a randomized trial suggests a transient benefit in endometriosis,but a sustained benefit in unexplained infertility[J]. Hum Reprod, 2007, 22(11):2857-2862. DOI:10.1093/humrep/dem275.
[18]
Johnson NP. Review of lipiodol treatment for infertility - an innovative treatment for endometriosis-related infertility?[J]. Aust N Z J Obstet Gynaecol, 2014, 54(1):9-12. DOI:10.1111/ajo.12141.
[19]
Watson A, Vandekerckhove P, Lilford R, et al. A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography:a surprising result?[J]. Fertil Steril, 1994, 61(3):470-477. DOI:10.1016/s0015-0282(16)56578-9.
[20]
Dreyer K, van Eekelen R, Tjon-Kon-Fat RI, et al. The therapeutic effect of hysterosalpingography in couples with unexplained subfertility:a post-hoc analysis of a prospective multi-centre cohort study[J]. Reprod Biomed Online, 2019, 38(2):233-239. DOI:10.1016/j.rbmo.2018.11.005.
[21]
Huang Q, Mo L, Wang J, et al. Oil-soluble contrast medium bathing attenuated endometrial inflammation and improved endometrial receptivity in women with recurrent implantation failure:a descriptive study[J]. BMC Women's Health, 2024, 24(1):326. DOI:10.1186/s12905-024-03160-6.
[22]
Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women:a committee opinion[J]. Fertil Steril, 2021, 116(5):1255-1265. DOI:10.1016/j.fertnstert.2021.08.038.
[23]
Xie B, Huang Y, Hang F, et al. Impact of oil-based contrast agents in hysterosalpingography on fertility outcomes in endometriosis:a retrospective cohort study[J]. Reprod Biol Endocrinol, 2024, 22(1):19. DOI:10.1186/s12958-024-01190-1.
[24]
Wang R, Watson A, Johnson N, et al. Tubal flushing for subfertility[J]. Cochrane Database of Systematic Reviews, 2020, 2020(10): CD003718. DOI:10.1002/14651858.CD003718.pub5.
[25]
Guyatt GH, Oxman AD, Vist GE, et al. GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008, 336(7650):924-926. DOI:10.1136/bmj.39489.470347.AD.
[26]
多囊卵巢综合征诊治路径专家共识编写组. 多囊卵巢综合征诊治路径专家共识[J]. 中华生殖与避孕杂志, 2023, 43(4):337-345. DOI:10.3760/cma.j.cn101441-20220927-00417.
[27]
中国医师协会妇产科医师分会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南(第三版)[J]. 中华妇产科杂志, 2021, 56(12):812-824. DOI:10.3760/cma.j.cn112141-20211018-00603.
[28]
Maheux-Lacroix S, Boutin A, Moore L, et al. Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women:a systematic review with meta-analysis[J]. Hum Reprod, 2014, 29(5):953-963. DOI:10.1093/humrep/deu024.
[29]
Broeze KA, Opmeer BC, van Geloven N, et al. Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis[J]. Hum Reprod Update, 2011, 17(3):293-300. DOI:10.1093/humupd/dmq056.
[30]
林小娜, 黄国宁, 孙海翔, 等. 输卵管性不孕诊治的中国专家共识[J]. 生殖医学杂志, 2018, 27(11):1048-1056. DOI:10.3969/j.issn.1004-3845.2018.11.002.
[31]
American College of Obstetricians and Gynecologists. Infertility Workup for the Women's Health Specialist:ACOG Committee Opinion,Number 781[J]. Obstet Gynecol, 2019, 133(6):e377-e384. DOI:10.1097/AOG.0000000000003271.
[32]
中华医学会放射学分会介入专委会妇儿介入学组. 子宫输卵管造影中国专家共识[J]. 中华介入放射学电子杂志, 2018, 6(3):185-187. DOI: 10.3877/cma.j.issn.2095-5782.2018.03.001.
[33]
Evers JL, Land JA, Mol BW. Evidence-based medicine for diagnostic questions[J]. Semin Reprod Med, 2003, 21(1):9-15. DOI:10.1055/s-2003-39990.
[34]
杨一华, 黄国宁, 孙海翔, 等. 不明原因不孕症诊断与治疗中国专家共识[J]. 生殖医学杂志, 2019, 28(9):984-992. DOI:10.3969/j.issn.1004-3845.2019.09.002.
[35]
输卵管通畅性检查专家共识编写组. 输卵管通畅性检查专家共识[J]. 中华生殖与避孕杂志, 2021, 41(8):669-674. DOI:10.3760/cma.j.cn101441-20201112-00618.
[36]
Guideline Group on Unexplained Infertility, Romualdi D, Ata B, et al. Evidence-based guideline:unexplained infertility[J]. Hum Reprod, 2023, 38(10):1881-1890. DOI:10.1093/humrep/dead150.
[37]
Dessole S, Meloni GB, Capobianco G, et al. A second hysterosalpingography reduces the use of selective technique for treatment of a proximal tubal obstruction[J]. Fertil Steril, 2000, 73(5):1037-1039. DOI:10.1016/s0015-0282(00)00415-5.
[38]
Zafarani F, Ghaffari F, Ahmadi F, et al. Hysterosalpingography in the assessment of proximal tubal pathology:a review of congenital and acquired abnormalities[J]. Br J Radiol, 2021, 94(1122):20201386. DOI:10.1259/bjr.20201386.
[39]
Tan Y, Zheng S, Lei W, et al. Ethiodized poppyseed oil versus ioversol for image quality and adverse events in hysterosalpingography:a prospective cohort study[J]. BMC Med Imaging, 2019, 19(1):50. DOI:10.1186/s12880-019-0346-0.
[40]
中国妇幼保健协会放射介入专业委员会. 输卵管造影技术规范中国专家共识(2022年版)[J]. 中国实用妇科与产科杂志, 2022, 38(2):165-169. DOI:10.19538/j.fk2022020110.
[41]
Gillespie HW. The therapeutic aspect of hysterosalpingography[J]. Br J Radiol, 1965, 38:301-302. DOI:10.1259/0007-1285-38-448-301.
[42]
Fang F, Bai Y, Zhang Y, et al. Oil-based versus water-based contrast for hysterosalpingography in infertile women:a systematic review and meta-analysis of randomized controlled trials[J]. Fertil Steril, 2018, 110(1):153-160 e3. DOI:10.1016/j.fertnstert.2018.03.021.
[43]
Wang R, van Welie N, van Rijswijk J, et al. Effectiveness on fertility outcome of tubal flushing with different contrast media:systematic review and network meta-analysis[J]. Ultrasound Obstet Gynecol, 2019, 54(2):172-181. DOI:10.1002/uog.20238.
[44]
van Welie N, Dreyer K, van Rijswijk J, et al. Treatment effect of oil-based contrast is related to experienced pain at HSG:a post-hoc analysis of the randomised H2Oil study[J]. Hum Reprod, 2019, 34(12):2391-2398. DOI: 10.1093/humrep/dez206.
[45]
Dishuck CF, Perchik JD, Porter KK, et al. Advanced Imaging in Female Infertility[J]. Curr Urol Rep, 2019, 20(11):77. DOI:10.1007/s11934-019-0942-0.
[46]
Kerin JF, Williams DB, San Roman GA, et al. Falloposcopic classification and treatment of fallopian tube lumen disease[J]. Fertil Steril, 1992, 57(4):731-741. DOI:10.1016/s0015-0282(16)54951-6.
[47]
Totorikaguena L, Olabarrieta E, Matorras R, et al. Mu opioid receptor in the human endometrium:dynamics of its expression and localization during the menstrual cycle[J]. Fertil Steril, 2017, 107(4):1070-1077 e1. DOI:10.1016/j.fertnstert.2017.01.020.
[48]
Fukui A, Fujii S, Yamaguchi E, et al. Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization[J]. Am J Reprod Immunol, 1999, 41(6):413-422. DOI:10.1111/j.1600-0897.1999.tb00456.x.
[49]
Johnson JV, Montoya IA, Olive DL. Ethiodol oil contrast medium inhibits macrophage phagocytosis and adherence by altering membrane electronegativity and microviscosity[J]. Fertil Steril, 1992, 58(3):511-517. DOI:10.1016/s0015-0282(16)55254-6.
[50]
Sawatari Y, Horii T, Hoshiai H. Oily contrast medium as a therapeutic agent for infertility because of mild endometriosis[J]. Fertil Steril, 1993, 59(4):907-911. DOI:10.1016/s0015-0282(16)55880-4.
[51]
Izumi G, Koga K, Takamura M, et al. Oil-soluble contrast medium(OSCM) for hysterosalpingography modulates dendritic cell and regulatory T cell profiles in the peritoneal cavity:a possible mechanism by which OSCM enhances fertility[J]. J Immunol, 2017, 198(11):4277-4284. DOI:10.4049/jimmunol.1600498.
[52]
Rasmussen F, Lindequist S, Larsen C, et al. Therapeutic effect of hysterosalpingography:oil- versus water-soluble contrast media--a randomized prospective study[J]. Radiology, 1991, 179(1):75-78. DOI:10.1148/radiology.179.1.1848716.
[53]
Miyamoto Y, Tsujimoto T, Iwai K, et al. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol[J]. Invest Radiol, 1995, 30(9):538-543. DOI: 10.1097/00004424-199509000-00005.
[54]
Soules MR, Spadoni LR. Oil versus aqueous media for hysterosalpingography:a continuing debate based on many opinions and few facts[J]. Fertil Steril, 1982, 38(1):1-11. DOI: 10.1016/s0015-0282(16)46388-0.
[55]
Grant A. Infertility surgery of the oviduct[J]. Fertil Steril, 1971, 22(8):496-503.
[56]
Sulak PJ, Letterie GS, Coddington CC, et al. Histology of proximal tubal occlusion[J]. Fertil Steril, 1987, 48(3):437-440.
[57]
Kerin JF, Surrey ES, Williams DB, et al. Falloposcopic observations of endotubal isthmic plugs as a cause of reversible obstruction and their histological characterization[J]. J Laparoendosc Surg, 1991, 1(2):103-110. DOI:10.1089/lps.1991.1.103.
[58]
Capitanio GL, Ferraiolo A, Croce S, et al. Transcervical selective salpingography:a diagnostic and therapeutic approach to cases of proximal tubal injection failure[J]. Fertil Steril, 1991, 55(6):1045-1050. DOI:10.1016/s0015-0282(16)54350-7.
[59]
Novy MJ, Thurmond AS, Patton P, et al. Diagnosis of cornual obstruction by transcervical fallopian tube cannulation[J]. Fertil Steril, 1988, 50(3):434-440.
[60]
Luttjeboer FY, Verhoeve HR, van Dessel HJ, et al. The value of medical history taking as risk indicator for tuboperitoneal pathology:a systematic review[J]. BJOG, 2009, 116(5):612-625. DOI:10.1111/j.1471-0528.2008.02070.x.
[61]
Farhi J, Homburg R, Ben-Haroush A, et al. Male factor infertility may be associated with a low risk for tubal abnormalities[J]. Reprod Biomed Online, 2011, 22(4):335-340. DOI:10.1016/j.rbmo.2011.01.003.
[62]
Johnson NP, Bhattu S, Wagner A, et al. Lipiodol alters murine uterine dendritic cell populations:a potential mechanism for the fertility-enhancing effect of lipiodol[J]. Fertil Steril, 2005, 83(6):1814-1821. DOI:10.1016/j.fertnstert.2004.11.065.
[63]
Liang G, Zhu Q, He X, et al. Effects of oil-soluble versus water-soluble contrast media at hysterosalpingography on pregnancy outcomes in women with a low risk of tubal disease:study protocol for a randomised controlled trial[J]. BMJ Open, 2020, 10(10):e039166. DOI:10.1136/bmjopen-2020-039166.
[64]
Macer ML, Taylor HS. Endometriosis and infertility:a review of the pathogenesis and treatment of endometriosis-associated infertility[J]. Obstet Gynecol Clin North Am, 2012, 39(4):535-549. DOI:10.1016/j.ogc.2012.10.002.
[65]
de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility:pathophysiology and management[J]. Lancet, 2010, 376(9742):730-738. DOI:10.1016/S0140-6736(10)60490-4.
[66]
Fabio P, Laura L, Fernanda V, et al. Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions:results from a multicentric Italian study. Gruppo italiano per lo studio dell'endometriosi[J]. Hum Reprod, 1994, 9(6):1158-1162.
[67]
Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease,whereas deeply infiltrating endometriosis is associated with pelvic pain[J]. Fertil Steril, 1991, 55(4):759-765. DOI:10.1016/s0015-0282(16)54244-7.
[68]
Matorras R, Rodíquez F, Pijoan JI, et al. Epidemiology of endometriosis in infertile women[J]. Fertil Steril, 1995, 63(1):34-38. DOI:10.1016/s0015-0282(16)57293-8.
[69]
Brent K, Hadden WE, Weston-Webb M, et al. After the FLUSH trial:A prospective observational study of lipiodol flushing as an innovative treatment for unexplained and endometriosis-related infertility[J]. Aust N Z J Obstet Gynaecol, 2006, 46(4):293-297. DOI:10.1111/j.1479-828X.2006.00595.x.
[70]
Geenen RWF, van der Molen AJ, Dekkers IA, et al. Contrast media for hysterosalpingography:systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital Radiology[J]. Eur Radiol, 2024, 34(10):6435-6443. DOI:10.1007/s00330-024-10707-6.
[71]
Nugent D, Watson AJ, Killick SR, et al. A randomized controlled trial of tubal flushing with lipiodol for unexplained infertility[J]. Fertil Steril, 2002, 77(1):173-175. DOI:10.1016/s0015-0282(01)02925-9.
[72]
Nezhat C, Khoyloo F, Tsuei A, et al. The prevalence of endometriosis in patients with unexplained infertility[J]. J Clin Med, 2024, 13(2):444. DOI:10.3390/jcm13020444.
[73]
Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility:a guideline[J]. Fertil Steril, 2020, 113(2):305-322. DOI:10.1016/j.fertnstert.2019.10.014.
[74]
Siristatidis C, Bhattacharya S. Unexplained infertility:does it really exist? Does it matter?[J]. Hum Reprod, 2007, 22(8):2084-2087. DOI:10.1093/humrep/dem117.
[75]
Ghiasi M, Kulkarni MT, Missmer SA. Is endometriosis more common and more severe than it was 30 years ago?[J]. J Minim Invasive Gynecol, 2020, 27(2):452-461. DOI:10.1016/j.jmig.2019.11.018.
[76]
Littman E, Giudice L, Lathi R, et al. Role of laparoscopic treatment of endometriosis in patients with failed in vitro fertilization cycles[J]. Fertil Steril, 2005, 84(6):1574-1578. DOI:10.1016/j.fertnstert.2005.02.059.
[77]
Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility:a committee opinion[J]. Fertil Steril, 2012, 98(3):591-598. DOI:10.1016/j.fertnstert.2012.05.031.
[78]
Johnson NP. A review of the use of lipiodol flushing for unexplained infertility[J]. Treat Endocrinol, 2005, 4(4):233-243.DOI:10.2165/00024677-200504040-00004.
[79]
Huang Q, Hang F, Mo L, et al. Intrauterine infusion of oil-based medium in women with recurrent implantation failure before frozen embryo transfer:a randomized clinical trial[J]. Reprod Health, 2025, 22(1):171. DOI:10.1186/s12978-025-02138-3.
[80]
中华医学会放射学分会对比剂安全使用工作组. 碘对比剂使用指南(第2版)[J]. 中华医学杂志, 2014, 94(43):3363-3369. DOI:10.3760/cma.j.issn.1005-1201.2013.10.001.
[81]
Mekaru K, Kamiyama S, Masamoto H, et al. Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium[J]. Gynecol Endocrinol, 2008, 24(9):498-501. DOI:10.1080/09513590802246364.
[82]
So S, Yamaguchi W, Tajima H, et al. The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function[J]. Gynecol Endocrinol, 2017, 33(9):682-685. DOI:10.1080/09513590.2017.1307960.
[83]
Mathews DM, Peart JM, Sim RG, et al. The SELFI study:iodine excess and thyroid dysfunction in women undergoing oil-soluble contrast hysterosalpingography[J]. J Clin Endocrinol Metab, 2022, 107(12):3252-3260. DOI:10.1210/clinem/dgac546.
[84]
Li Y, Shan Z, Teng W, et al. The iodine status and prevalence of thyroid disorders among women of childbearing age in China:national cross-sectional study[J]. Endocr Pract, 2021, 27(10):1028-1033. DOI:10.1016/j.eprac.2021.03.017.
[85]
Poppe K, Glinoer D, Van Steirteghem A, et al. Thyroid dysfunction and autoimmunity in infertile women[J]. Thyroid, 2002, 12(11):997-1001. DOI:10.1089/105072502320908330.
[86]
Elahi S, Tasneem A, Nazir I, et al. Thyroid dysfunction in infertile women[J]. J Coll Physicians Surg Pak, 2007, 17(4):191-194.
[87]
Mathews DM, Peart JM, Sim RG, et al. Iodine and other factors associated with fertility outcome following oil-soluble contrast medium hysterosalpingography:a prospective cohort study[J]. Front Endocrinol(Lausanne), 2024, 15:1257888. DOI:10.3389/fendo.2024.1257888.
[88]
Roest I, van Welie N, Mijatovic V, et al. Complications after hysterosalpingography with oil- or water-based contrast:results of a nationwide survey[J]. Hum Reprod Open, 2020, 2020(1): hoz045. DOI:10.1093/hropen/hoz045.
[89]
Simpson WL Jr, Beitia LG, Mester J. Hysterosalpingography:a reemerging study[J]. Radiographics, 2006, 26(2):419-431. DOI:10.1148/rg.262055109.
[90]
Dusak A, Soydinc HE, Onder H, et al. Venous intravasation as a complication and potential pitfall during hysterosalpingography:re-emerging study with a novel classification[J]. J Clin Imaging Sci, 2013, 3:67. DOI:10.4103/2156-7514.124105.
[91]
Naorungroj T, Naksanguan T, Chinthammitr Y. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review[J]. J Med Assoc Thai, 2013, 96(Suppl 2):S270-S275.
[92]
Nunley WC Jr, Bateman BG, Kitchin JD 3rd, et al. Intravasation during hysterosalpingography using oil-base contrast medium--a second look[J]. Obstet Gynecol, 1987, 70(3 Pt 1):309-312.
[93]
Gowin W, Fuchs P. Pericaval intravasation of contrast media in the changed indication for hysterosalpingography[J]. Rontgenblatter, 1984, 37(1):26-28.
[94]
Perisinakis K, Damilakis J, Grammatikakis J, et al. Radiogenic risks from hysterosalpingography[J]. Eur Radiol, 2003, 13(7):1522-1528. DOI:10.1007/s00330-002-1809-0.
[95]
Lu J, Qi D, Xu W. Fertility-enhancing effect of oil-based contrast agents during hysterosalpingography and the variation of this effect within a 3-year follow-up period in infertile patients[J]. Front Med(Lausann), 2022, 9:948945. DOI:10.3389/fmed.2022.948945.
[96]
van Welie N, Rosielle K, Dreyer K, et al. How long does the fertility-enhancing effect of hysterosalpingography with oil-based contrast last?[J]. Reprod Biomed Online, 2020, 41(6):1038-1044. DOI:10.1016/j.rbmo.2020.08.038.
[97]
张子秋, 张宇萌, 夏丹丹, 等. 碘油子宫输卵管造影3种延迟摄片时间对比[J]. 分子影像学杂志, 2024, 47(6):609-615. DOI:10.12122/j.issn.1674-4500.2024.06.09.
[98]
Lu J, Qi D, Liu Y, et al. A prospective self-controlled study on shortening the time before taking delayed radiographs with iodized oil hysterosalpingography[J]. Ginekol Pol, 2020, 91(11):655-660. DOI:10.5603/GP.a2020.0121.
[99]
Wang Y. Comparison of the diagnostic consistency between delayed radiographs taken two hours and twenty-four hours post hysterosalpingography using ultra-fluid lipiodol-based contrast medium[J]. Curr Med Imaging, 2025 Sep 18. DOI:10.2174/0115734056258980231112082655.
[100]
中国医师协会介入医师分会妇儿介入专委会, 中华医学会放射学分会介入学组泌尿生殖专业委员会. 输卵管介入治疗中国专家共识[J]. 中华介入放射学电子杂志, 2019, 7(3):175-177. DOI:10.3877/cma.j.issn.2095-5782.

脚注

利益冲突 所有作者均声明不存在利益冲突

基金

广西重点研发计划(桂科AB22035080)

PDF(1158 KB)

Accesses

Citation

Detail

段落导航
相关文章

/